 | • レポートコード：TMR2008015 • 出版社/出版日：Transparency Market Research / 2020年6月 • レポート形態：英文、PDF、218ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、創薬アウトソーシングの世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、サービスタイプ別（生物学的サービス、化学サービス、リード識別・スクリーニング、リード最適化、その他）分析、薬物種類別（小型分子、大型分子）分析、治療部位別（呼吸器系、抗感染、腫瘍、心血管、胃腸）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・創薬アウトソーシングの世界市場：サービスタイプ別（生物学的サービス、化学サービス、リード識別・スクリーニング、リード最適化、その他） ・創薬アウトソーシングの世界市場：薬物種類別（小型分子、大型分子） ・創薬アウトソーシングの世界市場：治療部位別（呼吸器系、抗感染、腫瘍、心血管、胃腸） ・創薬アウトソーシングの世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Drug Discovery Outsourcing Market – Scope of the Report
TMR’s report on the global drug discovery outsourcing market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global drug discovery outsourcing market from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global drug discovery outsourcing market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global drug discovery outsourcing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global drug discovery outsourcing market.
The report delves into the competition landscape of the global drug discovery outsourcing market. Key players operating in the global drug discovery outsourcing market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global drug discovery outsourcing market report.
Key Questions Answered in Drug Discovery Outsourcing Market Report
What will be the sales revenue generated by drug discovery outsourcing across all regions during the forecast period?
What are the key trends in the global drug discovery outsourcing market?
What are major drivers, restraints, and opportunities in the global drug discovery outsourcing market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which therapeutic area segment will generate the maximum revenue by 2030 and which service type segment will expand at the fastest CAGR during the forecast period?
Drug Discovery Outsourcing Market – Research Objectives and Research Approach
The comprehensive report on the global drug discovery outsourcing market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global drug discovery outsourcing market. It is followed by market introduction, market dynamics, and an overview of the global drug discovery outsourcing market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global drug discovery outsourcing market report highlights USPs, which include key mergers & acquisitions, technological advancements in drug discovery, Drug Discovery Process – an Overview, COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry, overview of companies outsourcing to CROs, Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced, and Porter’s Five Force Analysis in the global drug discovery outsourcing market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key players in the global drug discovery outsourcing market has been mapped to ascertain the size of the market in terms of value. The forecast presented here assesses the total revenue generated in the global drug discovery outsourcing market. In order to provide an accurate forecast, we initiated by sizing up the current drug discovery outsourcing market with the help of the parent market.
The report analyzes the global drug discovery outsourcing market in terms of service type, drug type, therapeutic area, and region. Key segments under each criteria have been studied at length and the market share of each of these by the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global drug discovery outsourcing market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug Discovery Outsourcing Market
4. Market Overview
4.1. Definition
4.2. Market Indicators
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030
4.5. Global Drug Discovery Outsourcing Market Outlook
5. Key Insights
5.1. Key Mergers & Acquisition
5.2. Technological Advancements in Drug Discovery
5.3. Drug Discovery Process – an Overview
5.4. COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry
5.5. Overview of Companies outsourcing to CROs
5.6. Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced
6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Service Type
6.1. Introduction
6.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type
6.3. Global Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
6.3.1. Biological Services
6.3.2. Chemical Services
6.3.3. Lead Identification & Screening
6.3.4. Lead Optimization
6.3.5. Others
6.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type
7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Type
7.1. Introduction
7.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type
7.3. Global Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
7.3.1. Small Molecules
7.3.2. Large Molecules
7.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type
8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area
8.1. Introduction
8.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area
8.3. Global Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
8.3.1. Respiratory System
8.3.2. Anti-infective
8.3.3. Oncology
8.3.4. Cardiovascular
8.3.5. Gastrointestinal
8.3.6. Central Nervous System
8.3.7. Immunomodulation
8.3.8. Others
8.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area
9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region
9.1. Regional Outlook
9.2. Introduction
9.3. Global Drug Discovery Outsourcing Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region
10. North America Drug Discovery Outsourcing Market Analysis and Forecast
10.1. Key Findings
10.2. North America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
10.2.1. Biological Services
10.2.2. Chemical Services
10.2.3. Lead Identification & Screening
10.2.4. Lead Optimization
10.2.5. Others
10.3. North America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
10.3.1. Small Molecules
10.3.2. Large Molecules
10.4. North America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
10.4.1. Respiratory System
10.4.2. Anti-infective
10.4.3. Oncology
10.4.4. Cardiovascular
10.4.5. Gastrointestinal
10.4.6. Central Nervous System
10.4.7. Immunomodulation
10.4.8. Others
10.5. North America Drug Discovery Outsourcing Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Drug Discovery Outsourcing Market Attractiveness Analysis
10.6.1. By Service Type
10.6.2. By Drug Type
10.6.3. By Therapeutic Area
10.6.4. By Country
11. Europe Drug Discovery Outsourcing Market Analysis and Forecast
11.1. Key Findings
11.2. Europe Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
11.2.1. Biological Services
11.2.2. Chemical Services
11.2.3. Lead Identification & Screening
11.2.4. Lead Optimization
11.2.5. Others
11.3. Europe Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
11.3.1. Small Molecules
11.3.2. Large Molecules
11.4. Europe Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
11.4.1. Respiratory System
11.4.2. Anti-infective
11.4.3. Oncology
11.4.4. Cardiovascular
11.4.5. Gastrointestinal
11.4.6. Central Nervous System
11.4.7. Immunomodulation
11.4.8. Others
11.5. Europe Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Drug Discovery Outsourcing Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By Drug Type
11.6.3. By Therapeutic Area
11.6.4. By Country/Sub-region
12. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast
12.1. Key Findings
1.1. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
12.1.1. Biological Services
12.1.2. Chemical Services
12.1.3. Lead Identification & Screening
12.1.4. Lead Optimization
12.1.5. Others
12.2. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
12.2.1. Small Molecules
12.2.2. Large Molecules
12.3. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
12.3.1. Respiratory System
12.3.2. Anti-infective
12.3.3. Oncology
12.3.4. Cardiovascular
12.3.5. Gastrointestinal
12.3.6. Central Nervous System
12.3.7. Immunomodulation
12.3.8. Others
12.4. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis
12.5.1. By Service Type
12.5.2. By Drug Type
12.5.3. By Therapeutic Area
12.5.4. By Country/Sub-region
13. Latin America Drug Discovery Outsourcing Market Analysis and Forecast
13.1. Key Findings
13.2. Latin America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
13.2.1. Biological Services
13.2.2. Chemical Services
13.2.3. Lead Identification & Screening
13.2.4. Lead Optimization
13.2.5. Others
13.3. Latin America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
13.3.1. Small Molecules
13.3.2. Large Molecules
13.4. Latin America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
13.4.1. Respiratory System
13.4.2. Anti-infective
13.4.3. Oncology
13.4.4. Cardiovascular
13.4.5. Gastrointestinal
13.4.6. Central Nervous System
13.4.7. Immunomodulation
13.4.8. Others
13.5. Latin America Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By Drug Type
13.6.3. By Therapeutic Area
13.6.4. By Country/Sub-region
14. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast
14.1. Key Findings
14.2. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030
14.2.1. Biological Services
14.2.2. Chemical Services
14.2.3. Lead Identification & Screening
14.2.4. Lead Optimization
14.2.5. Others
14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030
14.3.1. Small Molecules
14.3.2. Large Molecules
14.4. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030
14.4.1. Respiratory System
14.4.2. Anti-infective
14.4.3. Oncology
14.4.4. Cardiovascular
14.4.5. Gastrointestinal
14.4.6. Central Nervous System
14.4.7. Immunomodulation
14.4.8. Others
14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis
14.6.1. By Service Type
14.6.2. By Drug Type
14.6.3. By Therapeutic Area
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2019
15.3. Company Profiles
15.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. WuXi AppTec Co., Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Albany Molecular Research Inc. (AMRI)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. GVK Biosciences Private Limited
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Sygnature Discovery
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Pharmaron Beijing Co., Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. WuXi Biologics (Cayman), Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. Domainex Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Thermo Fisher Scientific, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
15.3.10. Jubilant Biosys Ltd.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.3.11. Evotec SE
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Strategic Overview
15.3.11.5. SWOT Analysis
15.3.12. Eurofins Discovery
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Strategic Overview
15.3.12.5. SWOT Analysis
15.3.13. GenScript Biotech Corporation
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Strategic Overview
15.3.13.5. SWOT Analysis
List of TablesTable 01: Companies entering into partnerships with CROs for drug discovery
Table 02: Integrated Drug Discovery – Key Players
Table 03: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 04: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 05: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 06: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 07: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 08: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 09: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 10: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 11: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 12: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 13: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 14: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 15: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 16: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 17: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 18: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 19: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 20: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 21: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 22: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030
Table 23: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 24: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 25: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 26: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030